Table 3.
Difference in current practice and a no screening trial strategy from 2020/21 to 2024/25.
Year | 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 |
---|---|---|---|---|---|
No. patients with SCS | 619 | 640 | 663 | 687 | 711 |
No. patients with a screening trial | 619 | 640 | 663 | 687 | 711 |
No. patients with unsuccessful screening trial | 66 | 68 | 71 | 73 | 76 |
Cost difference between current practice and no screening trial (per patient ~£700) | £433,189 | £448,534 | £464,421 | £480,872 | £497,905 |
SCS, spinal cord stimulation.